Publications by authors named "Clement Bonnet"

Claim this Profile
P
Palliative care outpatient interventions to limit aggressive care at end-of-life for patients with advanced soft tissue sarcomas.
Laura Thery, Thomas Zurecki, Carole Bouleuc, Clément Bonnet, Sylvie Bonvalot

Support Care Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic changes in mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomas.
Maria Kfoury, Clément Bonnet, Nicolas Delanoy, Karen Howarth, Christophe Marzac

Int J Gynecol Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Management of gastrointestinal stromal tumors].
Sarah Watson, Clément Bonnet

Rev Prat· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM4 amplification in atypical lipomatous tumors/well-differentiated liposarcoma: Private event or alternative oncogenic mechanism?
Nadège Gruel, Sophie El Zein, Dimitri Tzanis, Nayla Nicolas, Aurélien Maraval, Clément Bonnet

Genes Chromosomes Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 Pembrolizumab.
Lounes Djerroudi, Julien Masliah-Planchon, Hervé J Brisse, Sophie El Zein, Sylvie Helfre, Clément Bonnet

JCO Precis Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?
Yohan Fayet, Christine Chevreau, Gauthier Decanter, Cécile Dalban, Pierre Meeus, Clément Bonnet

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era.
Valéry Refeno, Michele Lamuraglia, Safae Terrisse, Clément Bonnet, Clément Dumont

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copper at the crossroads: Assessment of the interactions between low-carbon energy transition and supply limitations.
Gondia Sokhna Seck, Emmanuel Hache, Clément Bonnet, Marine Simoën, Samuel Carcanague

Resour Conserv Recycl· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding chemotherapy-induced changes in bladder cancer biology: a necessary step towards tailored treatment in cisplatin-refractory disease.
Clément Dumont, Hélène Gauthier, Clément Bonnet, Stéphane Culine

Transl Androl Urol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials.
Jean-Marie Michot, Lina Benajiba, Laura Faivre, Capucine Baldini, Lelia Haddag, Clement Bonnet

Invest New Drugs· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Atezolizumab (Tecentriq): Activity, indication and modality of use in advanced or metastatic urinary bladder carcinoma].
Alice Bernard-Tessier, Clément Bonnet, Pernelle Lavaud, Marco Gizzi, Yohann Loriot

Bull Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential drug-drug interactions with abiraterone in metastatic castration-resistant prostate cancer patients: a prevalence study in France.
Clément Bonnet, Pascaline Boudou-Rouquette, Esther Azoulay-Rutman, Olivier Huillard, Jean-Louis Golmard

Cancer Chemother Pharmacol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
Frédéric Bigot, Clément Bonnet, Christophe Massard

Bull Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobile applications in oncology: is it possible for patients and healthcare professionals to easily identify relevant tools?
Benoit Brouard, Pascale Bardo, Clément Bonnet, Nicolas Mounier, Marina Vignot

Ann Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[ESMO ECCO 2015: The highlights of immunotherapy and targeted therapies].
Clément Bonnet, Guillaume Beinse, Luc Cabel, Delphine Cochereau, Pernelle Lavaud

Bull Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Mobile applications in oncology available for French users: Who's behind?].
Benoît Brouard, Pascale Bardo, Clément Bonnet, Marina Vignot, Stéphane Vignot

Bull Cancer· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[eHealth and mHealth: current developments in 2014 and perspectives in oncology].
Benoît Brouard, Pascale Bardo, Marina Vignot, Clément Bonnet, Stéphane Vignot

Bull Cancer· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis